glp-1 and addiction Not just obesity: receptor agonists advance on Weight Loss Drugs May Also
Description
You're literally trading long-term performance for short-term results on a scale
The study highlights that after stopping GLP-1 medications, many patients resume treatment or try alternatives, influencing weight management strategies.
The second study analyzed the effect of a monoclonal antibody that inhibits muscle mass loss, but found limited benefit
KIDNEY FUNCTION
